Home  ■  Participation  ■  Assessments  ■  Epitopes  ■  Protocols  ■  Techniques  ■  Links
 

Seminars

  

Seminars and workshops planned 2008
27-29 August 2008
Aalborg		 NordiQC Workshop in Diagnostic Immunohistochemistry.
Information and programme: Click on NordiQC-workshop-08.pdf (update 18 June 2008)

Due to the great interest in the workshop, it will be repeated spring 2009. The date is not settled yet. A waiting list is established. E-mail nordiqc@rn.dk for further information.
Wednesday 29 October 2008, Copenhagen

Meeting language: Danish/Scandinavian

Mammakarcinom: Patoanatomiske undersøgelse - diagnostiske, prognostiske og terapeutiske markører

I samarbejde med Dansk Selskab for Cytokemi og Histokemi og DBCGs patologiudvalg

Program (update 18 June 2008)
   

Previous seminars 2006
30 May 2006
Copenhagen

Immunohistochemical tumour markers and their quality assurance

In collaboration with Danish Society for Cytochemistry and Histochemistry
Programme Markers of testicular tumours and precursor lesions (Grete Krag Jacobsen) QA of germ cell markers (MV/SN)
Abstracts Markers of Prostate carcinomas and precursor lesions (Astrid Petersen) QA of prostate markers (MV/SN)
  NordiQC Proceedings (MV/SN) Open forum: diversity of neurofilament (MV)
  Markers of breast carcinoma and precursor lesions (Birgitte Bruun Rasmussen) QA of breast markers (MV/SN)
  Breast carcinoma: HER-2 amplification and overexpression (Jorma Isola) QA of HER-2 (MV/SN)

Posters 2006
IAP Congress  Montreal September 2006

Nordic immunohistochemical Quality Control
Previous seminars 2005
17 Oct /16 Nov 2005
Uppsala / Oslo		 Antibody algorithm for the unknown primary tumour (M Vyberg) [pdf]
  "Difficult" markers in previous NordiQC runs (M Vyberg) [pdf]
  Run 15: IgK and IgL (B Risberg) [pdf]
  How to compose control tissue blocks (S Nielsen) [link]
  The HER-2/breast cancer scheme (M Vyberg) [pdf]
  NordiQC scheme 2006 - new markers (M Vyberg) [pdf]
Previous seminars 2004
27 may 2004
Copenhagen		 Abstracts
  The NordiQC organization (M Vyberg)
Basic markers of haematolymphoid neoplasms (E Torlakovic)
Markers of melanocytic tumours (T Seidal)
Hormone receptors in breast carcinomas (H Helin)
Transcription factors in diagnostic pathology (E Torlakovic)
Markers of carcinomas: The unknown primary (M Vyberg)
Experiences with NordiQC . . . (S Nielsen)
MV

Last update 18-06-2008